A detailed history of Valeo Financial Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Valeo Financial Advisors, LLC holds 3,014 shares of MRNA stock, worth $111,065. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,014
Previous 3,067 1.73%
Holding current value
$111,065
Previous $364,000 44.78%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$63.64 - $125.14 $3,372 - $6,632
-53 Reduced 1.73%
3,014 $201,000
Q2 2024

Jul 10, 2024

SELL
$101.21 - $166.61 $24,189 - $39,819
-239 Reduced 7.23%
3,067 $364,000
Q1 2024

Apr 25, 2024

BUY
$85.37 - $115.44 $96,809 - $130,908
1,134 Added 52.21%
3,306 $352,000
Q1 2024

Apr 19, 2024

SELL
$85.37 - $115.44 $203,607 - $275,324
-2,385 Reduced 52.34%
2,172 $231,000
Q4 2023

Jan 29, 2024

SELL
$69.51 - $104.43 $8,063 - $12,113
-116 Reduced 2.48%
4,557 $453,000
Q3 2023

Oct 19, 2023

BUY
$96.41 - $126.61 $82,334 - $108,124
854 Added 22.36%
4,673 $482,000
Q2 2023

Jul 14, 2023

BUY
$118.5 - $160.53 $38,394 - $52,011
324 Added 9.27%
3,819 $464,000
Q1 2023

Apr 17, 2023

SELL
$135.66 - $197.02 $16,007 - $23,248
-118 Reduced 3.27%
3,495 $536,000
Q4 2022

Feb 09, 2023

BUY
$118.38 - $210.04 $122,641 - $217,601
1,036 Added 40.2%
3,613 $648,000
Q3 2022

Oct 31, 2022

SELL
$118.07 - $194.18 $18,300 - $30,097
-155 Reduced 5.67%
2,577 $305,000
Q2 2022

Aug 03, 2022

BUY
$117.13 - $176.59 $78,945 - $119,021
674 Added 32.75%
2,732 $390,000
Q1 2022

Apr 28, 2022

BUY
$126.46 - $235.05 $78,531 - $145,966
621 Added 43.22%
2,058 $355,000
Q4 2021

Jan 07, 2022

BUY
$225.82 - $368.51 $24,840 - $40,536
110 Added 8.29%
1,437 $365,000
Q3 2021

Nov 02, 2021

BUY
$221.9 - $484.47 $11,316 - $24,707
51 Added 4.0%
1,327 $511,000
Q2 2021

Jul 22, 2021

SELL
$129.91 - $234.98 $58,459 - $105,741
-450 Reduced 26.07%
1,276 $300,000
Q1 2021

Apr 12, 2021

BUY
$109.18 - $185.98 $52,515 - $89,456
481 Added 38.63%
1,726 $226,000
Q4 2020

Feb 11, 2021

SELL
$65.74 - $169.86 $60,217 - $155,591
-916 Reduced 42.39%
1,245 $130,000
Q3 2020

Oct 28, 2020

SELL
$54.34 - $94.85 $2,934 - $5,121
-54 Reduced 2.44%
2,161 $153,000
Q2 2020

Jul 20, 2020

BUY
$29.67 - $80.0 $12,313 - $33,200
415 Added 23.06%
2,215 $142,000
Q1 2020

Apr 13, 2020

BUY
$17.78 - $31.58 $19,558 - $34,738
1,100 Added 157.14%
1,800 $57,000
Q1 2019

Apr 12, 2019

BUY
$14.45 - $23.7 $10,115 - $16,590
700 New
700 $14,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.